a cannula was implanted in the right lateral ventricle of the brain while the animal was under light barbiturate anesthesia (Nembutal, 20 mg/kg, ip) and at least 2 or 3 days were allowed for recovery. The cannula was made from polyethylene tubing (PE-IO), cut to a length of 4 cm. The method involved forming a small bulb in the cannula by momentarily heating a small annular section of the tubing.
A drill was used to make a hole in the skull which exactly fitted the outer dimensions of the cannula. The latter was then inserted by hand directly into the hole until the bulb rested against the surface of the skull. Further details of this method were described by Altaffer et al.
(1). Animals implanted with this type of cannula have been used, when required, for several months with minimal loss due to blockage or damage to the cannulas. In our experiments, the implanted rats were then placed in individual cages, and for 2 consecutive days their spontaneous food intake was measured hourly, beginning at 10 AM, for the next 6 hr. For each group treatment, at each hour of the experiment, the ingested food was calculated as the difference between the food intake on the experimental day and the mean food intake during the same time on the 2 days prior to the experiment.
Tap water was available during the experiment, but water intake was not measured. When used in combination with Z-DG, drugs were given immediately before the systemic administration of the latter. Drug doses are expressed as free base.
Blockade of catecholamine (CA) synthesis by a-methyltyrosine (a-MT).
Blockade of CA synthesis was accomplished by Dr.=a-methyl-p-tyrosine methyl ester (Kistner Labtjanst AB, Goteborg) (3 1), with a dose of the substance (50 mg/kg) which has been shown to decrease brain catecholamine levels by about 40 % for at least 12 hr (8). After 2 days of basal measurements of food intake, at 6 AM of the experimental day, three groups of rats were injected with saline (0.5 ml/l00 g body wt, ip-first group) or a-MT methyl ester (50 mg/kg, ip in 0.5 ml saline-second and third groups).
At 10 AM the first and second groups received intraperitoneally the usual dose of Z-DG, while the third group was injected intraperitoneally with saline. Food intake was then determined for the next 6 hr at hourly intervals.
6-Hydroxydopamine experiments. In experiments designed to test the effect of Z-DG on the food intake of rats whose central adrenergic terminals had been chemically destroyed, Sprague-Dawley female rats, 130-140 g body wt, received through the implanted cannula 20 ~1 of a solution of 6-hydroxydopamine hydrobromide or of the vehicle. The 6-hydroxydopamine (6-OHDA) was dissolved in pyrogen-free saline containing ascorbic acid (1 mg/ml). The solution was prepared just before use and was kept on ice (34). Doses of 6-OHDA are expressed in terms of the salt. Two injections were given, 200 and 100 pug (1 week apart) ; all control animals were injected with an equal volume of the vehicle solution. After an interval of 12 days from the first administration of the drug, to allow the reestablishment of the preinjection food intake, controls and 6-OHDA treated rats were given 2-DG (750 mg/kg ip) at 10 AM of the day of the experiment, and food intake was then determined at hourly intervals for 6 hr, as previously described. At the completion of the experiment, animals were killed by decapitation, brains were removed and weighed, the hypothalamus was removed, dissected at 4 C according to the procedure of Glowinski and Iversen (14) it appears that the administration of 750 mg/kg ip of 2-DG increased food intake about threefold starting from the 2nd hr after the injection and for the rest of the test period. From the analysis of variance, it appears that the 2-DG-treated groups differ significantly from controls (F = 290.14, P < 0.01) and that two different trends in food intake are present during the experimental times (F = 18.10, P < 0.01). A s a result of 2-DG administration, drowsiness, stupor, and ataxia were noticed; these were especially prominent in the first 2 hr. Action of adrenergic a-and P-blockers on Z-DG-induced hyperphagia. Before evaluating the ability of the drugs used to influence 2-DG hyperphagia, their effect on food intake was assessed in the absence of the glucose inhibitor.
It is apparent from Fig. 2 Mean values of food intake in 7 experiments during the 6 hr following ip injection of 2DG. Number of rats (n) = 40. Brackets stand for &SE. 2. Effect of intraventricular administration of phentolamine or propranolol on basal food intake. Saline, phentolamine, or propranolol were given intraventricularly at 10 AM and food intake was measured during following 6 hr. n = 6 for saline and phentolamine; n = 10 for saline and propranolol.
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This same description also applies to Figs. 3-g. (Fig. 7) . No gross changes in behavior were noticed in the cr-MT treated animals.
2-DG hyp er a ia in animals treated with 6-OHDA. Intraph g ventricular administration of the first dose of 6-OHDA (200 pg) resulted in a prompt decrease of food intake and body weight which lasted 1 day. Some animals developed convulsions and two animals died. When the treatment was Data were obtained by pooled results of 2 separate experiments. n = 8, 7 for saline; n = 6, 6 for phentolamine. repeated (100 pug 6-OHDA), the effect on food intake and body weight was less evident and was present also in the animals that received the diluent intraventricularly (Fig. 8) . Twelve days after the first injection of 6-OHDA, when food intake was back to normal, the animals underwent the experiments with Z-DG. As with a-MT, chemical sympathectomy by 6-OHDA resulted in a profound reduction and delay of the hyperphagic response (saline vs. 6-OHDA: F= 8.12, P < 0.01) (Fig. 9) . Determination of brain CA levels showed that 6-OHDA treatment resulted in 70.5 and 32.8 % reduction of NE and DA, respectively, in the whole brain, while in the hypothalamus the percent reduction of NE was 36.6 %. The method used for brain CA determination did not allow the measurement of DA in a single hypothalamus (Table 1) . 8. Food intake and body weight changes of rats after intraventricular administration of 6-hydroxydopamine (6-OHDA). On 12th day after 1st injection of 6-OHDA, animals underwent '2-DG experiment (see Fig. 9 ).
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DISCUSSION
The results of these studies are compatible with the view that adrenergic mediation plays a role in the Z-DG-induced eating response. Minute amounts of the a-noradrenergic antagonists phentolamine and azapetine, when administered by the intraventricular route concomitantly with Z-DG, reduced the latter drug's stimulant effect on food intake. Administration of a lower dose (10 rug) of phentolamine did not appear to diminish the amount of food ingested so drastically.
The similar effect exhibited by azapetine, the most active adrenergic blocking agent of the dibenzazepine series (27), is difficult to reconcile with the possibility that the action of phentolamine on Z-DG hyperphagia was unrelated to a-adrenergic blockade. Specificity of a-receptor blockade is suggested by the failure to obtain suppressive effects with the highly potent ,&adrenolytic agent, propranolol.
Indeed, in three separate experiments this drug did not affect the stimulant action of Z-DG, and similar results were obtained with MJ-1999, another highly active and selective P-blocker (19). The present findings agree with the reported ineffectiveness of propranolol in preventing the eating response due to intrahypothalamic noradrenaline administration (19) . Similarly to the a-noradrenergic antagonists, a-methyltyrosine, a specific inhibitor of CA biosynthesis (31), in a dose that lowers brain levels of noradrenaline and dopamine (8) but is unable to affect the basal consumption of food, reduced significantly the hyperphagic effect of Z-DG. Intraventricular 6-OHDA produces a selective degeneration of catecholaminergic nerve terminals with consequent loss of noradrenaline and dopamine (34). In rats pretreated with 6-OHDA, in which the basal food intake had returned to normal after a transient hypophagia, the eating response elicited by Z-DG was markedly reduced, even though not In agreement with the present findings on basal intake of food after 6-OHDA treatment, it has been reported recently that stereotactic injections of this chemical along the medial forebrain bundle into the lateral hypothalamic area induces only transient aphagia and adipsia (30). The pronounced effect of 6-OHDA on the response to Z-DG at a time when there is no effect on ad libitum feeding would imply a participation of the brain catecholaminergic system only in the i nitiation of feeding by glucoprivic receptors, a mechanism that is not essential for commonplace feeding or body-weight regulation in the multifactor scheme (17). "satiety" cells, whose ,&satiety terminations, in turn, would inhibit feeding neurons in the lateral hypothalamus, on which the P-satiety receptors are located, and thereby induce anorexia., In the present experiments, since the CY blockers were injected into the lateral ventricle, they could have acted almost anywhere in the brain adjacent to the ventricular system to produce their action. The recent observations of Berger et al. (4), however, that intraventricular administration of phentolamine suppressed feeding in rats that had recovered from lateral hypothalamic lesions, while in keeping with the present findings, strongly favor the lateral hypothalamus as the site of action of the a-adrenolytic drugs. It appears of interest in this context that the lateral hypothalamus and the immediately adjacent structures are a major focus for some essential portion of the system that mobilizes food intake during glucoprivation; rats that are eating and regulating food intake after recovery from the initial aphagia and anorexia induced by lateral hypothalamic lesions do not eat more during insulininduced hypoglycemia (12) and start eating after intraventricular administration of noradrenaline (4). Their analogy with the phentolamine-hypophagic rats after the glucoprivation by 2-DG seems to be more than coincidental and strongly suggests the participation of the adrenergic system in the glucoprivic control of feeding in the lateral hypothalamus.
On recalling that brain CA systems in the infant rat are far from being competent (18, 22) and Teitelbaum's concept (32) that, with respect to feeding, the rat with lateral hypothalamic lesions is more like an infant than an adult, one is tempted to speculate that in both situations the critical common denominator resides in an inadequacy of the central adrenergic circuits. However, since Leibowitz's studies have shown that the a-hunger receptors are predominantly located in and act to inhibit the ventromedial satiety area, one cannot dismiss the possibility that the reported effects of the a-blockers might be a consequence of the inhibition of an adrenergic inhibiting tone at the level of the ventromedial nucleus. Thus, the possible participation of the ventromedial satiety device to the feeding response induced by acute glucoprivation will be the subject of further investigations. to noradrenaline (6). Quite recently,
